114 related articles for article (PubMed ID: 20018010)
1. Simultaneous genome-wide association studies of anti-cyclic citrullinated peptide in rheumatoid arthritis using penalized orthogonal-components regression.
Lin Y; Zhang M; Wang L; Pungpapong V; Fleet JC; Zhang D
BMC Proc; 2009 Dec; 3 Suppl 7(Suppl 7):S20. PubMed ID: 20018010
[TBL] [Abstract][Full Text] [Related]
2. Case-control genome-wide association study of rheumatoid arthritis from Genetic Analysis Workshop 16 using penalized orthogonal-components regression-linear discriminant analysis.
Zhang M; Lin Y; Wang L; Pungpapong V; Fleet JC; Zhang D
BMC Proc; 2009 Dec; 3 Suppl 7(Suppl 7):S17. PubMed ID: 20018006
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide single-nucleotide polymorphism linkage analyses of quantitative rheumatoid arthritis phenotypes in Caucasian NARAC families.
Taylor KE; Chen W; Amos CI; Criswell LA
BMC Proc; 2007; 1 Suppl 1(Suppl 1):S105. PubMed ID: 18466445
[TBL] [Abstract][Full Text] [Related]
4. Identification of correlated genetic variants jointly associated with rheumatoid arthritis using ridge regression.
Sun YV; Shedden KA; Zhu J; Choi NH; Kardia SL
BMC Proc; 2009 Dec; 3 Suppl 7(Suppl 7):S67. PubMed ID: 20018061
[TBL] [Abstract][Full Text] [Related]
5. Data for Genetic Analysis Workshop 16 Problem 1, association analysis of rheumatoid arthritis data.
Amos CI; Chen WV; Seldin MF; Remmers EF; Taylor KE; Criswell LA; Lee AT; Plenge RM; Kastner DL; Gregersen PK
BMC Proc; 2009 Dec; 3 Suppl 7(Suppl 7):S2. PubMed ID: 20018009
[TBL] [Abstract][Full Text] [Related]
6. Adjusting for HLA-DRbeta1 in a genome-wide association analysis of rheumatoid arthritis and related biomarkers.
Matthews AG; Li J; He C; Ott J; Andrade Md
BMC Proc; 2009 Dec; 3 Suppl 7(Suppl 7):S12. PubMed ID: 20017985
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis.
Cui J; Taylor KE; Destefano AL; Criswell LA; Izmailova ES; Parker A; Roubenoff R; Plenge RM; Weinblatt ME; Shadick NA; Karlson EW
Mol Med; 2009; 15(5-6):136-43. PubMed ID: 19287509
[TBL] [Abstract][Full Text] [Related]
8. A quantile-based method for association mapping of quantitative phenotypes: an application to rheumatoid arthritis phenotypes.
Ghosh S; Sanapala KR; Ghosh A; Chakladar S
BMC Proc; 2009 Dec; 3 Suppl 7(Suppl 7):S18. PubMed ID: 20018007
[TBL] [Abstract][Full Text] [Related]
9. Power of selective genotyping in genome-wide association studies of quantitative traits.
Xing C; Xing G
BMC Proc; 2009 Dec; 3 Suppl 7(Suppl 7):S23. PubMed ID: 20018013
[TBL] [Abstract][Full Text] [Related]
10. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
11. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
[No Abstract] [Full Text] [Related]
12. Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis.
Patsopoulos NA; Ioannidis JP
Ann Rheum Dis; 2010 Mar; 69(3):561-6. PubMed ID: 19401279
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
14. Replication of Associations of Genetic Loci Outside the HLA Region With Susceptibility to Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
Viatte S; Massey J; Bowes J; Duffus K; ; Eyre S; Barton A; Worthington J
Arthritis Rheumatol; 2016 Jul; 68(7):1603-13. PubMed ID: 26895230
[TBL] [Abstract][Full Text] [Related]
15. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.
Ding B; Padyukov L; Lundström E; Seielstad M; Plenge RM; Oksenberg JR; Gregersen PK; Alfredsson L; Klareskog L
Arthritis Rheum; 2009 Jan; 60(1):30-8. PubMed ID: 19116921
[TBL] [Abstract][Full Text] [Related]
16. [The clinical informativeness of detection of antibodies to citrullinated proteins under rheumatoid arthritis].
Cherkasova MV; Novikov AA; Alexndrova EN; Karateev DE; Popkova TV; Luchikhina EL; Avdeeva AS; Nasonov EL
Klin Lab Diagn; 2015 Feb; 60(2):46-9. PubMed ID: 26027260
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
[TBL] [Abstract][Full Text] [Related]
18. Association of anti-citrullinated vimentin and anti-citrullinated α-enolase antibodies with subsets of rheumatoid arthritis.
Montes A; Perez-Pampin E; Calaza M; Gomez-Reino JJ; Gonzalez A
Arthritis Rheum; 2012 Oct; 64(10):3102-10. PubMed ID: 22674012
[TBL] [Abstract][Full Text] [Related]
19. [The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.].
Machado SH; von Mühlen CA; Brenol JC; Bisotto L; Xavier RM
J Pediatr (Rio J); 2005; 81(6):491-4. PubMed ID: 16327935
[TBL] [Abstract][Full Text] [Related]
20. [The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis].
Machado SH; von Mühlen CA; Brenol JC; Bisotto L; Xavier RM
J Pediatr (Rio J); 2005; 81(6):491-4. PubMed ID: 16385368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
